Our oncology pharmacy residency program helps residents develop expertise and competency in providing pharmaceutical care services to cancer patients in both inpatient and ambulatory settings. Required rotations include adult and pediatric oncology, bone marrow transplant, oral chemotherapy, infusion and hospice/palliative care. Longitudinal experiences include administration, research, tumor board attendance, participation in an oncology pharmacy and therapeutics (P&T) committee. Residents will also have opportunities to teach through direct precepting of PGY1 residents and students as well as opportunities to lecture in the oncology module and participate in the oncology elective at Idaho State University.
This 12-month program offers an approximately $50,000 stipend, benefits, and paid time off.
Residency Start Date: July 6, 2020
Oncology research (with concentrated opportunities)
Oncology administration (with additional concentrated rotation elective available)
Application Deadline: January 3, 2020
Applicants must have a PharmD degree or equivalent, eligibility for Idaho licensure, CV, 3 letters of recommendation (1 from PGY1 RPD) and completion of PGY1 residency. Please visit the link below to apply:
For questions, please contact:
Robert Mancini, PharmD, BCOP
PGY2 Residency Program Director
Phone: (208) 381-4141
The PGY2 Oncology Pharmacy Residency conducted by St. Luke's Health System, Boise, ID is accredited by ASHP.